TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Takeda Pharma A/S
Closing information (x1000 NOK)
| Closing information | 2025/03 | 2024/03 | 2023/03 |
| Turnover |
1,686,289
|
1,754,866
|
1,613,834 |
| Earnings before taxes |
26,225
|
526,639
|
31,711 |
| Total assets |
889,224
|
913,535
|
738,707 |
| Current assets |
861,300
|
858,073
|
623,868 |
| Current liabilities |
311,554
|
338,386
|
570,697 |
| Equity capital |
563,352
|
558,363
|
144,307 |
| - share capital |
15,449
|
15,843
|
15,360 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Solvency |
63.4%
|
61.1%
|
19.5% |
| Turnover per employee |
4,818
|
5,014
|
4,611 |
| Profit as a percentage of turnover |
1.6%
|
30.0%
|
2.0% |
| Return on assets (ROA) | |||
| Current ratio |
276.5%
|
253.6%
|
109.3% |
| Return on equity (ROE) |
4.7%
|
94.3%
|
22.0% |
| Change turnover |
-24,919
|
90,204
|
229,859 |
| Change turnover % |
-1%
|
5%
|
17% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.